Financhill
Back

Harmony Biosciences Holdings Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
3

HRMY
Harmony Biosciences Holdings

Last Price:
29.50
Seasonality Move:
7.42%
Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
15.22
Seasonality Move:
8.98%
Sell
3
Harmony Biosciences Holdings (HRMY) is a Sell

Is Harmony Biosciences Holdings a Buy, Sell or Hold?

  • The current Harmony Biosciences Holdings [HRMY] share price is $29.50. The Score for HRMY is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • HRMY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.22. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HRMY Stock Price Chart

What is Harmony Biosciences Holdings's stock price today?

  • The Harmony Biosciences Holdings share price today is $29.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRMY is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

HRMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.02 Sell
Chaikin Money Flow: -250648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.35 - 32.97) Sell
Bollinger Bands (100): (30.19 - 33.21) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 44.9 Sell
Chaikin Money Flow: -550362 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.46 - 16.38) Sell
Bollinger Bands (100): (13.89 - 16.13) Buy

HRMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.54 Sell
20-day SMA: 31.9 Sell
50-day SMA: 32.03 Sell
200-day SMA: 31.59 Sell
8-day EMA: 30.64 Sell
20-day EMA: 31.35 Sell
50-day EMA: 31.66 Sell
200-day EMA: 32.8 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.5 Sell
20-day SMA: 15.83 Sell
50-day SMA: 15.17 Buy
200-day SMA: 14.09 Buy
8-day EMA: 15.58 Sell
20-day EMA: 15.67 Sell
50-day EMA: 15.41 Sell
200-day EMA: 14.52 Buy

Harmony Biosciences Holdings Earnings Growth & HRMY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.38 per share, an increase this year of $0.59 per share, and an increase next year of $1.63 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Harmony Biosciences Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):